Drug Trial Radar · NCT05666362
Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening
Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
68
Actual
Start
Jan 20, 2023
Primary completion
Dec 20, 2024
Study completion Jan 15, 2025
Sponsor
- Lead sponsor
- Alexandria UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 27, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 4 weeks, up to 12 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study of cerebral hemodynamic changes in preterm infant and the effect of topical anesthetic eye drops ( benoxinate hydrochloride 0.4% ) on PIPP score and cerebral hemodynamic changes during fundus examination in neonates with gestational age ≤ 34 weeks or birth weight ≤ 2.000 Kg regardless their gestational age , after postnatal day 28.
Conditions
- Preterm
Interventions
benoxinate hydrochloride 0.4% groupDrug
They will receive benoxinate hydrochloride 0.4% immediately before fundus
saline 0.9% .Drug
They will receive saline 0.9% before fundus examination in each eye .
Primary outcomes
What the sponsor says the trial is designed to measure.
- 1-Clinical assessment:Time frame: 28 days postnatal age (time of screen of retinopathy of prematurity ,ROP)
- 2-Near-infrared spectroscopy (NIRS):Time frame: 28 days postnatal age (time of screen of retinopathy of prematurity ,ROP)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Marwa Mohamed Farag
Alexandria, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.